Evidence map›Paper›PMID 39919117›Full record

ArticlePLoS pathogens2025

Alternative lipid synthesis in response to phosphate limitation promotes antibiotic tolerance in Gram-negative ESKAPE pathogens.

Roberto Jhonatan Olea-Ozuna, Melanie J Campbell, Samantha Y Quintanilla, Sinjini Nandy, Jennifer S Brodbelt, Joseph M Boll

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Adaptive Response ofAntibiotics (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Sphingolipid-mediated vesiculation in multidrug-resistantApplied and environmental microbiology · 2025
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Roberto Jhonatan Olea-OzunaDepartment of Biological Sciences, University of Texas at Dallas, Richardson, Texas, United States of America.
Melanie J CampbellDepartment of Chemistry, University of Texas at Austin, Austin, Texas, United States of America.
Samantha Y QuintanillaDepartment of Biological Sciences, University of Texas at Dallas, Richardson, Texas, United States of America.
Sinjini NandyDepartment of Biological Sciences, University of Texas at Dallas, Richardson, Texas, United States of America.
Jennifer S BrodbeltDepartment of Chemistry, University of Texas at Austin, Austin, Texas, United States of America.
Joseph M BollDepartment of Biological Sciences, University of Texas at Dallas, Richardson, Texas, United States of America.ORCID 0000-0003-1412-9780

Funding

Ultraviolet Photodissociation Mass Spectrometry for Characterization of Biological MoleculesR35GM139658 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI BRODBELT, JENNIFER S. · 2021 to 2025
$2.9M
Mechanistic basis of how LD-transpeptidases protect against outer membranedefectsR01AI168159 · NIAID · UNIVERSITY OF TEXAS DALLAS · PI Joseph Michael Boll · 2022 to 2026
$2.3M
Reinforcing the barrier: Understanding how cell envelope modifications promote intrinsic antimicrobial tolerance and resistance in Acinetobacter baumanniiR35GM143053 · NIGMS · UNIVERSITY OF TEXAS DALLAS · PI BOLL, JOSEPH MICHAEL · 2021 to 2025
$1.9M
NIAID NIH HHS R01 AI168159NIGMS NIH HHS R35 GM139658NIGMS NIH HHS R35 GM143053
6 · The paper itself

Abstract

The Gram-negative outer membrane protects bacterial cells from environmental toxins such as antibiotics. The outer membrane lipid bilayer is asymmetric; while glycerophospholipids compose the periplasmic facing leaflet, the surface layer is enriched with phosphate-containing lipopolysaccharides. The anionic phosphates that decorate the cell surface promote electrostatic interactions with cationic antimicrobial peptides such as colistin, allowing them to penetrate the bilayer, form pores, and lyse the cell. Colistin is prescribed as a last-line therapy to treat multidrug-resistant Gram-negative infections. Acinetobacter baumannii is an ESKAPE pathogen that rapidly develops resistance to antibiotics and persists for extended periods in the host or on abiotic surfaces. Survival in environmental stress such as phosphate scarcity, represents a clinically significant challenge for nosocomial pathogens. In the face of phosphate starvation, certain bacteria encode adaptive strategies, including the substitution of glycerophospholipids with phosphorus-free lipids. In bacteria, phosphatidylethanolamine, phosphatidylglycerol, and cardiolipin are conserved glycerophospholipids that can form lipid bilayers, particularly in the presence of other lipids. Here, we demonstrate that in response to phosphate limitation, conserved regulatory mechanisms induce alternative lipid production in A. baumannii. Specifically, phosphate limitation induces formation of three lipids, including amine-containing ornithine and lysine aminolipids. Mutations that inactivate aminolipid biosynthesis exhibit fitness defects relative to wild type in colistin growth and killing assays. Furthermore, we show that other Gram-negative ESKAPE pathogens accumulate aminolipids under phosphate limiting growth conditions, suggesting aminolipid biosynthesis may represent a broad strategy to overcome cationic antimicrobial peptide-mediated killing.

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsAnti-Bacterial AgentsPhosphatesColistinDrug Resistance, BacterialGlycerophospholipidsAnti-Bacterial AgentsColistinGlycerophospholipidsPhosphates

Identifiers

PMID39919117
PMCPMC11828411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.